No black box warning on record for Lithium

As of the latest FDA labeling reviewed, Lithium (LITHIUM CITRATE) does not carry a black box warning. Standard warnings and precautions still apply — see the full Lithium medicine page for the complete safety profile.

Other warnings & precautions

5 WARNINGS AND PRECAUTIONS Lithium-Induced Polyuria: May develop during initiation of treatment. Increases risk of lithium toxicity. Educate patient to avoid dehydration. Monitor for lithium toxicity and metabolic acidosis. Discontinue lithium or treat with amiloride as a therapeutic agent ( 5.2 ). Hyponatremia: Symptoms are more severe with faster-onset hyponatremia. Dehydration from protracted s

No black box warning on record for Lithium

Other warnings & precautions

5 WARNINGS AND PRECAUTIONS Lithium-Induced Polyuria: May develop during initiation of treatment. Increases risk of lithium toxicity. Educate patient to avoid dehydration. Monitor for lithium toxicity and metabolic acidosis. Discontinue lithium or treat with amiloride as a therapeutic agent ( 5.2 ). Hyponatremia: Symptoms are more severe with faster-onset hyponatremia. Dehydration from protracted s

Lithium Black Box Warning

No black box warning on record for Lithium

Other warnings & precautions

Lithium Black Box Warning

No black box warning on record for Lithium

Other warnings & precautions